Statistics for The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists
Total visits
| views | |
|---|---|
| The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists | 162 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists.pdf | 22 |
| The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists.pdf | 7 |
| The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists.pdf(legacy) | 4 |
Top country views
| views | |
|---|---|
| United States | 41 |
| Chile | 33 |
| Germany | 29 |
| Russia | 2 |
| AP | 1 |
| China | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 27 |
| Concepcion | 5 |
| Balingen | 4 |
| Kempen | 2 |
| Alameda | 1 |
| Campbell | 1 |
| Jacksonville | 1 |
| Sacramento | 1 |
| Vilsbiburg | 1 |
| Zapopan | 1 |